Project Number 20141110-Rosenzweig-Lipson-2014 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2014 View Full Project Details for Accelerating a Phase III MCI Clinical Trial with Phase I Evaluation of a Novel Extended-Release Levetiracetam Formulation Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator ROSENZWEIG-LIPSON, SHARON Principal Investigator First Name SHARON Principal Investigator Last Name ROSENZWEIG-LIPSON Awardee Organization AGENEBIO, INC. Awardee State Indiana Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $900,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
